User profiles for PETER A. MERKEL
Peter MerkelVerified email at upenn.edu Cited by 60981 |
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative
Objective The 1980 American College of Rheumatology (ACR) classification criteria for
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …
[HTML][HTML] Rituximab versus cyclophosphamide for ANCA-associated vasculitis
JH Stone, PA Merkel, R Spiera, P Seo… - … England Journal of …, 2010 - Mass Medical Soc
Background Cyclophosphamide and glucocorticoids have been the cornerstone of
remission-induction therapy for severe antineutrophil cytoplasmic antibody (ANCA)−associated …
remission-induction therapy for severe antineutrophil cytoplasmic antibody (ANCA)−associated …
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
…, HM Kremers, MD Mayes, PA Merkel… - Arthritis & …, 2008 - Wiley Online Library
Objective. To provide a single source for the best available estimates of the US prevalence of
and number of individuals affected by arthritis overall, rheumatoid arthritis, juvenile arthritis, …
and number of individuals affected by arthritis overall, rheumatoid arthritis, juvenile arthritis, …
2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody–associated vasculitis
…, MF Ibarra, LF Imundo, S Kim, PA Merkel… - Arthritis & …, 2021 - Wiley Online Library
Objective To provide evidence‐based recommendations and expert guidance for the
management of antineutrophil cytoplasmic antibody–associated vasculitis (AAV), including …
management of antineutrophil cytoplasmic antibody–associated vasculitis (AAV), including …
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
In this article, the 2009 European League Against Rheumatism (EULAR) recommendations
for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (…
for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (…
EULAR recommendations for the management of primary small and medium vessel vasculitis
Objectives: To develop European League Against Rheumatism (EULAR) recommendations
for the management of small and medium vessel vasculitis. Methods: An expert group (…
for the management of small and medium vessel vasculitis. Methods: An expert group (…
ANCA-associated vasculitis
The anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are a group
of disorders involving severe, systemic, small-vessel vasculitis and are characterized by …
of disorders involving severe, systemic, small-vessel vasculitis and are characterized by …
2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of giant cell arteritis and Takayasu arteritis
…, MF Ibarra, LF Imundo, S Kim, PA Merkel… - Arthritis & …, 2021 - Wiley Online Library
Objective To provide evidence‐based recommendations and expert guidance for the
management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large vessel …
management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large vessel …
[HTML][HTML] Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis
Background Eosinophilic granulomatosis with polyangiitis is an eosinophilic vasculitis.
Mepolizumab, an anti–interleukin-5 monoclonal antibody, reduces blood eosinophil counts and …
Mepolizumab, an anti–interleukin-5 monoclonal antibody, reduces blood eosinophil counts and …
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis
…, A Hutchings, RA Watts, PA Merkel… - Arthritis & …, 2022 - Wiley Online Library
Objective To develop and validate revised classification criteria for granulomatosis with
polyangiitis (GPA). Methods Patients with vasculitis or comparator diseases were recruited into …
polyangiitis (GPA). Methods Patients with vasculitis or comparator diseases were recruited into …